BioSig Technologies (BSGM) | Stock Overview & Key Data
BioSig Technologies Performance Comparison
Stock Range
Today's Range
Low: $5.42
High: $5.85
on October 2, 2025
52 Week Range
Low: $0.23
High: $14.11
on October 14, 2024
on July 8, 2025
All-Time High: $124.30 on May 11, 2020
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$195.4M
EPS
-1.05
P/E Ratio (TTM)
-7.39
Forward P/E
-8.03
P/B Ratio
-44.12
PEG Ratio
-0.05
Div. Yield
N/A
ROE
739.31%
Beta
1.824
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
N/A
Operating Margin
-211,407.70%
Profit Margin
0.00%
Returns and Earnings
Return on Assets (TTM)
-30.45%
Return on Equity (TTM)
739.31%
EBITDA
$-26.8M
Net Income (TTM)
$-26.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$0.00
Quarterly Revenue Growth (YoY)
N/A
Quarterly Earnings Growth (YoY)
-100.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| BioSig Technologies BSGM | 195.40M Micro-cap | 2.40% | 17.12% | -42.59% | 965.38% | 295.71% | 1,746.67% | -31.69% | -89.74% |
| Abbott Laboratories ABT | 234.39B Mega-cap | 0.78% | 1.82% | 0.11% | 2.25% | 18.64% | 19.49% | 32.22% | 22.75% |
| Boston Scientific BSX | 144.20B Large-cap | -0.88% | -9.50% | -6.71% | -1.20% | 8.88% | 15.12% | 144.77% | 136.56% |
| Monogram MGRM | 248.68M Micro-cap | 3.38% | 1.66% | 110.69% | 125.46% | 156.72% | 163.36% | -54.74% | -54.74% |
| Inogen INGN | 235.33M Micro-cap | 5.23% | 9.77% | 15.49% | 22.70% | -5.88% | -5.15% | -60.68% | -72.14% |
| TriSalus Life TLSI | 232.86M Micro-cap | -1.70% | -7.23% | -8.88% | -11.49% | -7.23% | 1.54% | -53.57% | -55.23% |
Ownership & Short Interest
Insider Ownership
28.73%
Institutional Ownership
28.66%
Shares Short
2M
Short Ratio
2.24
Short % of Shares Outstanding
5.91%
Average 10-Day Volume
1M
Average 90-Day Volume
1M
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is BSGM's 52-week high and low?
- In the last 52 weeks, BioSig Technologies reached a high of $14.11 (on July 8, 2025) and a low of $0.23 (on October 14, 2024).
- What is the market cap and P/E ratio for BSGM?
- Curious about BioSig Technologies's size and valuation? Its market capitalization stands at 195.40M. When it comes to valuation, the P/E ratio (trailing twelve months) is -7.39, and the forward P/E (looking ahead) is -8.03.
- Does BSGM pay dividends? If so, what's the yield?
- As for dividends, BioSig Technologies isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are BioSig Technologies's main competitors or similar companies to consider before investing?
When looking at BioSig Technologies, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Abbott Laboratories
ABT234.39B Healthcare Medical Devices 19.49% 32.22% Boston Scientific
BSX144.20B Healthcare Medical Devices 15.12% 144.77% Monogram
MGRM248.68M Healthcare Medical Devices 163.36% -54.74% Inogen
INGN235.33M Healthcare Medical Devices -5.15% -60.68% TriSalus Life
TLSI232.86M Healthcare Medical Devices 1.54% -53.57% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for BioSig Technologies Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of BioSig Technologies's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 739.31%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for BSGM?
- Looking at BioSig Technologies's growth, its revenue over the trailing twelve months (TTM) was $13K. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of -100.00%.
- How much of BSGM stock is held by insiders and institutions?
- Wondering who owns BioSig Technologies stock? Company insiders (like executives and directors) hold about 28.73% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 28.66%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.